Johnson johnson ordered to pay 110m in us talc cancer case

A significant development in the ongoing talc cancer litigation against Johnson & Johnson!

According to recent reports, a jury in St. Louis, Missouri has ordered Johnson & Johnson to pay $110 million in damages to a woman who claimed that the company's talcum powder products caused her ovarian cancer.

The lawsuit was filed by Lois Slemp, who alleged that she used Johnson & Johnson's Baby Powder and Shower to Shower products for decades, and that the talc in these products caused her to develop ovarian cancer in 2012. Slemp's case was one of thousands of similar lawsuits filed against Johnson & Johnson, which has been accused of downplaying the risks associated with talcum powder use and failing to warn consumers about the potential health risks.

The jury's verdict is the latest in a series of high-profile talc cancer cases against Johnson & Johnson. In 2018, the company was ordered to pay $4.69 billion in damages to 22 women who claimed that the company's talcum powder products caused their ovarian cancer. In 2019, a jury awarded $25.7 million to a woman who claimed that Johnson & Johnson's talcum powder products caused her mesothelioma, a rare and aggressive form of lung cancer.

Johnson & Johnson has consistently denied any wrongdoing and has maintained that its talcum powder products are safe for use. The company has also argued that the scientific evidence does not support a link between talcum powder use and ovarian cancer.

The $110 million verdict in the Slemp case is likely to be appealed by Johnson & Johnson, and the company has already announced its intention to do so. However, the verdict is a significant blow to the company's reputation and could have significant implications for its talcum powder business.

It's worth noting that the scientific community remains divided on the issue of whether talcum powder use increases the risk of ovarian cancer. While some studies have suggested a link between the two, others have found no such association. The US Food and Drug Administration (FDA) has not issued a warning about the use of talcum powder, and the American Cancer Society states that the evidence is "inconsistent" on the issue.

The ongoing litigation against Johnson & Johnson is likely to continue to play out in the courts, with many more cases pending against the company.